Wegovy Semaglutide 1.7mg FlexTouch Solution For Subcutaneous Injection In Pre-Filled Pen, Pack of 1's

Administer WEGOVY® once weekly as an adjunct to diet and increased physical activity, on the same day each week, at any time of day, with or without meals. Inject SUBCUTANEOUSLY in the abdomen, thigh or upper arm. |In patients with type 2 diabetes, monitor blood glucose prior to starting and during WEGOVY® treatment. |In studies with rodents, Wegovy® and medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. |The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.

The product description provided above is just a guideline and comes from the manufacturer or supplier. There can be a chance that some of the information might be incomplete or not entirely accurate. So, it is recommended to use this description as a guide, but make sure to check the detailed information once you have the product in hand. This includes information like description, benefits, usage instruction, any possible side effects, the ingredients, and any specific guidelines or warnings. If you have any questions or concerns about the product, feel free to reach out to one of our pharmacists in-store or give us a call at 800BINSINA for more assistance.

To reduce the risk of major adverse cardiovascular events |To reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity or overweight adults who have at least one weight-related comorbid condition |You will lose weight with Semaglutide because you will eat less, and feel fuller when you do eat